S
Surf Therapeutics develops a patented broad beam ultrasound platform designed to safely activate the body's cholinergic anti-inflammatory pathway. This non-invasive stimulation prompts the release of natural neurotransmitters to restore immune balance, shifting the body away from uncontrolled inflammation. The technology aims to provide therapeutic benefits and potentially long-lasting relief for inflammatory disorders without reliance on pharmaceuticals.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Surf Therapeutics utilizes a patented broad beam ultrasound platform to safely activate nerves using gentle acoustic energy. This activation prompts the release of natural neurotransmitters that signal the immune system to restore balance away from uncontrolled inflammation. The technology offers a non-invasive method to treat various autoimmune disorders by modulating the cholinergic anti-inflammatory pathway without relying on pharmaceuticals.